We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Andrx Pharmaceuticals has filed a citizen's petition with the FDA requesting
that the agency seek the advice of the FTC and the Justice Department on the
contentious issue of authorized generics.
A coalition of 10 large pharmaceutical firms has launched a discount card program
that could help millions of uninsured Americans save about 25 to 40 percent
on commonly used prescription drugs.
The FDA has issued a warning letter to the Respi Care Group
of Puerto Rico alerting the company it has committed "serious violations"
of the Federal Food, Drug, and Cosmetic Act.
The FDA has published a draft guidance to provide drugmakers with recommendations
on how to convert OTC drug monograph labeling to OTC "Drug Facts"
format.
Women's rights groups seeking easier access to emergency contraception are pressuring
U.S. regulators as they try to decide whether to approve a nonprescription "morning-after"
pill.
A pharmaceutical company has issued a nationwide recall of approximately 500
bottles of a drug used to treat attention-deficit/hyperactivity disorder and
narcolepsy.
Oxygen Healthcare, promoted by a group of UK-based NRIs, is setting up a world-class
research facility in Ahmedabad to offer contract chemistry in drug discovery
for bio-pharmaceutical companies based in Europe and the U.S.
Pharmacy benefits manager Caremark on Monday said all the products it sells
come from licensed wholesalers, a day after a published report said Illinois
regulators were investigating whether it resold drugs that had been returned
by patients.